Free Trial

Zimmer Biomet (ZBH) Stock Price, News & Analysis

Zimmer Biomet logo
$95.16 +1.69 (+1.81%)
Closing price 07/9/2025 03:57 PM Eastern
Extended Trading
$95.64 +0.48 (+0.50%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Zimmer Biomet Stock (NYSE:ZBH)

Key Stats

Today's Range
$92.71
$95.38
50-Day Range
$90.22
$102.08
52-Week Range
$89.22
$116.71
Volume
2.77 million shs
Average Volume
1.81 million shs
Market Capitalization
$18.83 billion
P/E Ratio
21.05
Dividend Yield
1.01%
Price Target
$110.00
Consensus Rating
Hold

Company Overview

Zimmer Biomet Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
99th Percentile Overall Score

ZBH MarketRank™: 

Zimmer Biomet scored higher than 99% of companies evaluated by MarketBeat, and ranked 27th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Zimmer Biomet has received a consensus rating of Hold. The company's average rating score is 2.32, and is based on 8 buy ratings, 9 hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    Zimmer Biomet has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Zimmer Biomet's stock forecast and price target.
  • Earnings Growth

    Earnings for Zimmer Biomet are expected to grow by 7.91% in the coming year, from $8.22 to $8.87 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zimmer Biomet is 21.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.93.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zimmer Biomet is 21.05, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.05.

  • Price to Earnings Growth Ratio

    Zimmer Biomet has a PEG Ratio of 2.16. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Zimmer Biomet has a P/B Ratio of 1.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Zimmer Biomet's valuation and earnings.
  • Percentage of Shares Shorted

    3.25% of the float of Zimmer Biomet has been sold short.
  • Short Interest Ratio / Days to Cover

    Zimmer Biomet has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Zimmer Biomet has recently increased by 16.52%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Zimmer Biomet pays a meaningful dividend of 1.03%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Zimmer Biomet does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Zimmer Biomet is 21.24%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Zimmer Biomet will have a dividend payout ratio of 10.82% next year. This indicates that Zimmer Biomet will be able to sustain or increase its dividend.

  • Read more about Zimmer Biomet's dividend.
  • Percentage of Shares Shorted

    3.25% of the float of Zimmer Biomet has been sold short.
  • Short Interest Ratio / Days to Cover

    Zimmer Biomet has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Zimmer Biomet has recently increased by 16.52%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Zimmer Biomet has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Zimmer Biomet this week, compared to 15 articles on an average week.
  • Search Interest

    4 people have searched for ZBH on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Zimmer Biomet to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zimmer Biomet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $95,000.00 in company stock.

  • Percentage Held by Insiders

    Only 1.39% of the stock of Zimmer Biomet is held by insiders.

  • Percentage Held by Institutions

    88.89% of the stock of Zimmer Biomet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Zimmer Biomet's insider trading history.
Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Stock News Headlines

WARNING: A Digital Dollar Is Still In The Works
A digital dollar could theoretically be used as a surveillance tool for banks, federal agencies, and the Federal Reserve.
ZBH - Zimmer Biomet Holdings Inc Chart | Morningstar
See More Headlines

ZBH Stock Analysis - Frequently Asked Questions

Zimmer Biomet's stock was trading at $105.63 at the start of the year. Since then, ZBH shares have decreased by 9.9% and is now trading at $95.16.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) posted its earnings results on Monday, May, 5th. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.04. The firm's revenue was up 1.1% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Zimmer Biomet: Respondwell, Clinical Graphics, CD Diagnostics, Medtech SAS, Compression Therapy Products, LDR Holding, Cayenne Medical, and others.

Zimmer Biomet's top institutional shareholders include Douglas Lane & Associates LLC (0.20%), Gradient Investments LLC (0.09%), Reinhart Partners LLC. (0.04%) and Czech National Bank (0.02%). Insiders that own company stock include Chad F Phipps, Sang Yi, Lori Winkler, Robert Hagemann, Michael W Michelson, Sreelakshmi Kolli and Betsy J Bernard.
View institutional ownership trends
.

Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zimmer Biomet investors own include Chevron (CVX), Bristol Myers Squibb (BMY), Comcast (CMCSA), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM).

Company Calendar

Record date for 4/30 Dividend
3/31/2025
Ex-Dividend for 4/30 Dividend
3/31/2025
Dividend Payable
4/30/2025
Last Earnings
5/05/2025
Record date for 7/31 Dividend
6/26/2025
Ex-Dividend for 7/31 Dividend
6/26/2025
Today
7/10/2025
Dividend Payable
7/31/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:ZBH
Previous Symbol
NYSE:ZMH
CIK
1136869
Employees
17,000
Year Founded
1927

Price Target and Rating

High Price Target
$135.00
Low Price Target
$95.00
Potential Upside/Downside
+15.6%
Consensus Rating
Hold
Rating Score (0-4)
2.32
Research Coverage
19 Analysts

Profitability

Trailing P/E Ratio
21.05
Forward P/E Ratio
11.58
P/E Growth
2.16
Net Income
$903.70 million
Pretax Margin
13.65%

Debt

Sales & Book Value

Annual Sales
$7.68 billion
Cash Flow
$13.44 per share
Price / Cash Flow
7.08
Book Value
$62.67 per share
Price / Book
1.52

Miscellaneous

Free Float
195,098,000
Market Cap
$18.83 billion
Optionable
Optionable
Beta
0.71

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:ZBH) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners